Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Virpax Pharmaceuticals Inc (NQ: VRPX )

0.5897 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Virpax Pharmaceuticals Inc

< Previous 1 2 3 4 5 6 Next >
Why Elastic Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Ericsson Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
This FactSet Research Analyst Turns Bearish; Here Are Top 4 Downgrades For Wednesday
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
VRPX Stock Earnings: Virpax Pharmaceuticals Reported Results for Q2 2024
Virpax Pharmaceuticals just reported results for the second quarter of 2024. 
Via InvestorPlace
Why Selective Insurance Group Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Dow Tumbles Over 100 Points; American Express Earnings Beat Views
Via Benzinga
Topics Earnings Stocks
Exposures Financial US Equities
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why Bloom Energy Group Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Latest Cannabis Hires And Board Changes, Here's What You Need To Know
Cannabis ancillary company EnWave Corporation (TSX-V: ENW) (FSE: E4U) announced on Thursday that it had tapped Danna Dunnage as its new vice president of global sales and business development. Dunnage... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why WD-40 Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Nasdaq Gains 1%; LegalZoom Shares Slide
Via Benzinga
S&P 500 Eyes Longest Streak Since October With 7 Straight
Stocks are higher midday, with the Dow Jones Industrial Average on track for its first daily win in three. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why Is Hawaiian Electric (HE) Stock Up 15% Today?
Hawaiian Electric stock is up on Wednesday after HE investors learned of a reported settlement tied to the 2023 Maui fires. 
Via InvestorPlace
Crude Oil Gains Over 1%; Virpax Pharmaceuticals Shares Spike Higher
Via Benzinga
Exposures Fossil Fuels
PLUG Stock: Plug Power Shares Hydrogen Refueling Station Update
Plug Power stock is up on Wednesday after the company provided investors with an update on its hydrogen refueling stations in Europe. 
Via InvestorPlace
Why Is Kazia Therapeutics (KZIA) Stock Up 300% Today?
Kazia Therapeutics stock is heading higher on Wednesday as KZIA investors celebrate positive clinical trial news from the company. 
Via InvestorPlace
Why Is Virpax Pharmaceuticals (VRPX) Stock Up 98% Today?
Virpax Pharmaceuticals stock is up on Wednesday as VRPX shareholders celebrate successful results from a swine model study. 
Via InvestorPlace
Pain Management-Focused Penny Stock Virpax Pharmaceuticals Surges Over 100% On Wednesday-Here's Why?
Virpax Pharmaceuticals reports positive results from a Swine Model pilot study of Probudur. Shares surged 169.8% on strong volume. Probudur showed a long-term, slow-release profile with no adverse... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.